Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 68382-923

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 68382-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 01

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 01
Chemical structure of eletriptan hydrobromide, showing the molecular arrangement with aromatic rings, a sulfone group, and a methylated nitrogen-containing heterocyclic ring.*
FDA Label Image

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 02

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 02
A line chart titled 'Estimated Probability of Initial Headache Response Within 2 Hours' showing the estimated probability of response on the vertical axis against time from initial dose in hours on the horizontal axis. The chart compares placebo with Eletriptan hydrobromide at 20 mg, 40 mg, and 80 mg doses, illustrating increased response probabilities over time for the Eletriptan groups compared to placebo.*
FDA Label Image

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 03

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 03
A line graph showing the estimated probability of taking a second dose or other medication over 24 hours following the first dose. The x-axis represents time from initial dose in hours (0 to 24), and the y-axis shows probability (0.0 to 0.9). Four lines represent Double Blind Placebo, Eletriptan 20 mg, Eletriptan 40 mg, and Eletriptan 80 mg, illustrating differences in medication-taking probability over time.*
FDA Label Image

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 04

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 04
Packaging label for Eletriptan Hydrobromide Tablets, 20 mg film-coated oral tablets. The label indicates a unit-dose package containing 6 tablets (1 x 6) and states prescription-only use. It includes manufacturer and distributor information for Zydus Pharmaceuticals USA Inc. and storage instructions. The design features the product name prominently with strength marked in blue boxes.*
FDA Label Image

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 05

788b8d6e F0c9 4f77 Bad8 A8b3e7f9c324 05
Packaging label for Eletriptan Hydrobromide Tablets, 40 mg, film-coated oral tablets by Zydus Pharmaceuticals USA Inc. The unit-dose package contains 6 tablets (1 x 6). The label notes the product is prescription only and not child-resistant, with storage instructions and manufacturer information included on the side panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.